Gang Liu
机构：University of Notre Dame, Boston University, Shenyang Aerospace University, Ministry of Education of the People's Republic of China, Central South University, Chongqing University, Xiamen University, Chengdu Medical College, First Affiliated Hospital of Chengdu Medical College, Changzhou University, Xiangya Hospital Central South University, Chongqing Medical and Pharmaceutical College, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University of Technology, Henan Medical University, Stanford University · ORCID：0000-0003-2613-7286
发表论文 1372 篇 · 总被引 50166 次 · h-index 112
代表论文
- Advanced Microsphere and Hydrogel Platforms for Precision Interventional Therapy of Hepatocellular Carcinoma (2025 · Chemistry - A European Journal · 被引 6)
- Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 4)
- Ultra-sensitive cardiac source imaging with SERF-MCG and advanced signal decoupling (2025 · Measurement · 被引 3)
- Hydrogel-based tumor embolization and synergistic therapeutic strategies (2025 · Bioactive Materials · 被引 2)
- Reprogramming Tumor Cell Death via Processing Natural Drug to Carbon Dots Overcomes Collagen Barrier and Activates Antitumor Immunity (2025 · Advanced Functional Materials · 被引 2)
- Regorafenib and R837 nanoparticle-stabilized Pickering emulsions overcome the angiogenesis-immune tolerance axis in transarterial chemoembolization (2026 · Biomaterials · 被引 1)